enVVeno Medical's First-in-Class enVVe System to Be Featured at The VEINS 2026 Innovation Summit as Company Advances Toward U.S. Pivotal TrialAccesswire · Oct 2, 2026
enVVeno Medical Presentation from H.C. Wainwright Conference Now Available On-DemandAccesswire · Sep 11, 2026
enVVeno Medical Participates in the Virtual Investor 'Why Now' On-Demand ConferenceAccesswire · Aug 27, 2026
Independent Health Economic Study Recently Published in Journal of Vascular Surgery Reports Economic Dominance of enVVeno Medical's Replacement Venous Valve Therapy Compared to Standard of Care TreatmentsAccesswire · Aug 4, 2026
enVVeno Medical Reports Second Quarter 2026 Financial Results and Advances Towards FDA Pivotal Trial for First-in-Class Non-Surgical Replacement Venous ValveAccesswire · Jul 31, 2026enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. The company's primary objective is to pioneer advanced bioprosthetic, tissue-engineered solutions intended to significantly elevate the existing standards of care for patients suffering from venous conditions. Their flagship product is the VenoValve, a specialized replacement venous valve developed for the management of chronic venous insufficiency.
| Date | Est. | Actual | |
|---|---|---|---|
| Jul 30, 2026 | -$4.69 | -$5.37 | Miss |
| May 7, 2026 | -$8.40 | -$5.89 | Beat |
| Mar 26, 2026 | -$9.80 | -$227.07 | Miss |
| Oct 29, 2025 | -$10.50 | -$281.75 | Miss |
| Jul 30, 2025 | -$9.80 | -$11.55 | Miss |
| Apr 30, 2025 | -$11.90 | -$7.70 | Beat |